Ashwin Ragupathi
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
-
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
- PARP inhibition in cancer therapy
Papers in
- Oncology 6
- HER2/EGFR in Cancer Research 4
- Peptidase Inhibition and Analysis 3
-
- Monoclonal and Polyclonal Antibodies Research 5
- Radiopharmaceutical Chemistry and Applications 4
- Co-authors
- Jason S. Lewis (9 shared papers)Patrícia M. R. Pereira (5 shared papers)Komal Mandleywala (5 shared papers)Lukas M. Carter (3 shared papers)Yelena Y. Janjigian (3 shared papers)Manrose Singh (2 shared papers)Dong Zhang (1 shared paper)R. Brian Dyer (2 shared papers)
- Journals
- Clinical Cancer Research (2 papers)Bioconjugate Chemistry (2 papers)Nature Communications (2 papers)Journal of Experimental Biology (1 paper)Journal of Nuclear Medicine (1 paper)
- Partner nations
- United States
In The Last Decade
Ashwin Ragupathi
15 papers receiving 481 citations
Peers
Comparison fields: 5 of 70
- Radiology, Nuclear Medicine and Imaging 200
- Oncology 165
- Immunology and Allergy 16
- Cancer Research 37
- Molecular Biology 173
Countries citing papers authored by Ashwin Ragupathi
This map shows the geographic impact of Ashwin Ragupathi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashwin Ragupathi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashwin Ragupathi more than expected).
Fields of papers citing papers by Ashwin Ragupathi
This network shows the impact of papers produced by Ashwin Ragupathi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashwin Ragupathi. The network helps show where Ashwin Ragupathi may publish in the future.
Co-authors
The 25 scholars most cited alongside Ashwin Ragupathi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 106 | |
| 2 | 2018 | 77 | |
| 3 | 2023 | 66 | |
| 4 | 2018 | 49 | |
| 5 | 2018 | 43 | |
| 6 | 2022 | 32 | |
| 7 | 2019 | 29 | |
| 8 | 2020 | 27 | |
| 9 | 2019 | 20 | |
| 10 | 2021 | 13 | |
| 11 | 2023 | 8 | |
| 12 | 2023 | 5 | |
| 13 | 2020 | 5 | |
| 14 | 2024 | 2 | |
| 15 | 2020 | 1 |
About Ashwin Ragupathi
Ashwin Ragupathi is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Immunology and Allergy, Molecular Biology and Materials Chemistry, having authored 15 papers that have together received 483 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers), HER2/EGFR in Cancer Research (4 papers), Peptidase Inhibition and Analysis (3 papers), Cell Adhesion Molecules Research (3 papers), Gold and Silver Nanoparticles Synthesis and Applications (1 paper), Click Chemistry and Applications (1 paper) and DNA Repair Mechanisms (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (200 citations), Oncology (165 citations), Immunology and Allergy (16 citations), Cancer Research (37 citations) and Molecular Biology (173 citations). Ashwin Ragupathi has collaborated with scholars based in United States. Frequent co-authors include Jason S. Lewis, Patrícia M. R. Pereira, Komal Mandleywala, Lukas M. Carter, Yelena Y. Janjigian, Manrose Singh, Dong Zhang, R. Brian Dyer, Brian M. Zeglis and Sophie Poty. Their work appears in journals such as Clinical Cancer Research, Bioconjugate Chemistry, Nature Communications, Journal of Experimental Biology and Journal of Nuclear Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.